Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O3VF
|
|||
Former ID |
DNC005257
|
|||
Drug Name |
2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one
|
|||
Synonyms |
CHEMBL362729; 503468-86-8; 2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one; 2-morpholin-4-yl-8-thiophen-2-yl-chromen-4-one; CTK1G6919; DTXSID30469303; BDBM50156496; AKOS030552940; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-(2-thienyl)-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H15NO3S
|
|||
Canonical SMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CS4
|
|||
InChI |
1S/C17H15NO3S/c19-14-11-16(18-6-8-20-9-7-18)21-17-12(14)3-1-4-13(17)15-5-2-10-22-15/h1-5,10-11H,6-9H2
|
|||
InChIKey |
FEOKXELSWFEHJU-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 503468-86-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA-dependent protein kinase catalytic (PRKDC) | Target Info | Inhibitor | [1] |
KEGG Pathway | Non-homologous end-joining | |||
Cell cycle | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
Pathway Interaction Database | DNA-PK pathway in nonhomologous end joining | |||
Coregulation of Androgen receptor activity | ||||
Class I PI3K signaling events mediated by Akt | ||||
BARD1 signaling events | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | |||
WikiPathways | DNA Damage Response | |||
Non-homologous end joining | ||||
FAS pathway and Stress induction of HSP regulation | ||||
Cytosolic sensors of pathogen-associated DNA | ||||
Retinoblastoma (RB) in Cancer | ||||
Prostate Cancer | ||||
Double-Strand Break Repair | ||||
Cell Cycle | ||||
miRNA Regulation of DNA Damage Response |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. J Med Chem. 2005 Dec 1;48(24):7829-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.